OTC/Rx Sodium Phosphate Laxative Claim Dispute Referred By NAD
This article was originally published in The Tan Sheet
Executive Summary
InKline Pharmaceuticals, which sells Rx sodium phosphate tablets, has declined to participate in the NAD self-regulatory forum, maintaining NAD is not the proper authority to review its marketing claims